MeSci
Senior Member (Voting Rights)
- G E Bekkering, guideline expert, methodologist1 2,
- T Agoritsas, doctor in general internal medicine, expert in shared decision making research3 4,
- L Lytvyn, patient partnership expert, methodologist4,
- A F Heen, general internist5,
- M Feller, general practitioner6 7,
- E Moutzouri, doctor in general internal medicine6 7,
- H Abdulazeem, patient partner8,
- B Aertgeerts, general practitioner1 2,
- D Beecher, patient partner9,
- J P Brito, endocrinologist10,
- P D Farhoumand, doctor in general internal medicine11,
- N Singh Ospina, endocrinologist12,
- N Rodondi, doctor in general internal medicine6 7,
- M van Driel, general practitioner13,
- E Wallace, general practitioner14,
- M Snel, endocrinologist15,
- P M Okwen, general practitioner16,
- R Siemieniuk, doctor in general internal medicine17,
- P O Vandvik, doctor in general internal medicine18 19 20,
- T Kuijpers, guideline expert, methodologist21,
- M Vermandere, general practitioner1
Clinical question What are the benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH)? This guideline was triggered by a recent systematic review of randomised controlled trials, which could alter practice.
Current practice Current guidelines tend to recommend thyroid hormones for adults with thyroid stimulating hormone (TSH) levels >10 mIU/L and for people with lower TSH values who are young, symptomatic, or have specific indications for prescribing.
Recommendation The guideline panel issues a strong recommendation against thyroid hormones in adults with SCH (elevated TSH levels and normal free T4 (thyroxine) levels). It does not apply to women who are trying to become pregnant or patients with TSH >20 mIU/L. It may not apply to patients with severe symptoms or young adults (such as those ≤30 years old).
https://www.bmj.com/content/365/bmj.l2006